Evergreen Capital Management’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$599K Buy
6,956
+2,051
+42% +$184K 0.01% 681
2025
Q4
$428K Buy
4,905
+897
+22% +$68.1K 0.01% 840
2025
Q3
$230K Buy
+4,008
New +$231K 0.01% 1148
2025
Q2
Sell
-3,702
Closed -$271K 1181
2025
Q1
$271K Buy
3,702
+689
+23% +$56.9K 0.01% 811
2024
Q4
$249K Buy
3,013
+190
+7% +$15K 0.01% 842
2024
Q3
$202K Buy
+2,823
New +$199K 0.01% 941

Other funds holding GMED

Evergreen Capital Management's GMED Position: Q1 2026 in Review

Evergreen Capital Management increased its Globus Medical (GMED) stake by 42% in Q1 2026, buying an estimated $184K and bringing the position to 6,956 shares worth $599K. The position accounts for 0.01% of the portfolio, ranked #681.

Evergreen Capital Management first reported a position in GMED in Q3 2024 and has held it in 6 quarters since. 602 funds tracked by Wall St. Rank hold GMED as of Q1 2026.

  • Evergreen Capital Management held 6,956 shares of Globus Medical worth $599K as of Q1 2026.
  • Evergreen Capital Management bought 2,051 Globus Medical shares in Q1 2026, an estimated $184K.
  • Globus Medical made up 0.01% of Evergreen Capital Management's portfolio in Q1 2026, its #681 holding.
  • Evergreen Capital Management first reported a position in Globus Medical in Q3 2024 and has held it in 6 quarters since.
  • 602 funds tracked by Wall St. Rank held Globus Medical as of Q1 2026.

Based on Evergreen Capital Management's 13F filing for Q1 2026, filed 14 May 2026.